(+)-pseudoephedrine sulfate clinical trials
A product of Pseudoephedrine; its studies count on that page too.
How each study uses (+)-pseudoephedrine sulfate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 18 Oct 1963 · DISOPHROL · NDA 013483 (FDA, Drugs@FDA; in a combination)
- European Union
- 30 Jul 2007 · Aerinaze · EMEA/H/C/000772 (EMA; as Pseudoephedrine; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2018 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Bayer (3) · Ranbaxy Laboratories Limited (1) · Azidus Brasil (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Pseudoephedrine
Studies
Open first, then newest update. How each study uses (+)-pseudoephedrine sulfate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic RhinitisWithdrawnPhase 3Azidus BrasilNCT01055756Written as Loratadine + Pseudoephedrine sulfateHow we know
- A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen ExposureCompletedPhase 4BayerNCT03443843Written as loratadine + pseudoephedrine sulfate (BAY818725/Claritin-D)How we know
- A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult SubjectsCompletedPhase 1BayerNCT03517930Written as Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)How we know
- A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult SubjectsCompletedPhase 1BayerNCT03517943Written as Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)How we know
- Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed ConditionsCompletedNot applicableRanbaxy Laboratories LimitedNCT00845546Written as 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release TabletsHow we know
Codes
What other systems call (+)-pseudoephedrine sulfate · ClinicalTrials.gg INT018574
- UNII (FDA) Y9DL7QPE6BPSEUDOEPHEDRINE SULFATEConfirmed FDA, Wikidata
- RxNorm 91169Confirmed FDA, Wikidata
- Wikidata Q27294410(+)-pseudoephedrine sulfateConfirmed FDA, Wikidata
- NCI Thesaurus C47696Pseudoephedrine SulfateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Y9DL7QPE6B | PSEUDOEPHEDRINE SULFATE | Confirmed FDA, Wikidata |
| RxNorm | 91169 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27294410 | (+)-pseudoephedrine sulfate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C47696 | Pseudoephedrine Sulfate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.